BIOMEA FUSION, INC. (BMEA)
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
Profusa Announces 1-for-4 Reverse Stock Split
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
SS&C GlobeOp Hedge Fund Performance Index and Capital Movement Index
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
SOLV Energy Reports Second Quarter 2026 Financial Results
Lantronix to Report Fiscal 2026 Fourth Quarter Results on Aug. 26, 2026
Telesat reports results for the three and six months ended June 30, 2026
Palomino Laboratories to Participate in the 7th Annual Needham Virtual Semiconductor & SemiCap Conference on August 20, 2026
ProQR Announces Second Quarter 2026 Operating and Financial Results
Stratasys Releases Second Quarter 2026 Financial Results
ScottsMiracle-Gro Brings America250’s “Our American Story” to ScottsMiracle-Gro Field
Legence Reports Second Quarter 2026 Financial Results
NMG présente le bilan du T2 2026 et souligne un trimestre charnière marqué par la transition du développement à l’exécution de la mine Matawinie
Rocket Lab Corporation Announces Progress on Iridium Acquisition: HSR Period Lapses; Form S-4 Filed; FCC Applications Filed; Capital Strategy Underway